Chargement en cours...
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938499/ https://ncbi.nlm.nih.gov/pubmed/24591838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39213 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|